T016 HHSN27200014 TA2 TO8 A Phase III Comparative Trial of Benzathine Penicillin G, 2.4 Million Units Administered as a Single Dose Versus Three Sucessive Weekly Doses for Treatment of Early Syphilis in Persons with and without HIV

Grant

Date/time Interval

  • May 1, 2019 - September 5, 2021
  • Total Award Amount

  • 1339905.00
  • Direct Costs

  • 1213915.00
  • Sponsor Award Id

  • HHSN272201300012I-HHSN27200014
  • Contributor

  • Edward Hook III   Investigator  
  • Jeanne Marrazzo   Principal Investigator  
  • Jodie Dionne-Odom   Investigator